How have UTMD shares performed in 2024?

Utah Medical Products' stock was trading at $84.22 at the beginning of 2024. Since then, UTMD stock has decreased by 18.9% and is now trading at $68.34. View the best growth stocks for 2024 here .

When is Utah Medical Products' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024. View our UTMD earnings forecast .

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) announced its quarterly earnings results on Tuesday, January, 30th. The medical instruments supplier reported $1.18 earnings per share for the quarter. The medical instruments supplier earned $12.33 million during the quarter. Utah Medical Products had a net margin of 33.12% and a trailing twelve-month return on equity of 13.53%.

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products announced a quarterly dividend on Tuesday, February 6th. Stockholders of record on Friday, March 15th will be given a dividend of $0.30 per share on Wednesday, April 3rd. This represents a $1.20 annualized dividend and a dividend yield of 1.76%. The ex-dividend date is Thursday, March 14th. Read our dividend analysis for UTMD .

Is Utah Medical Products a good dividend stock?

Utah Medical Products (NASDAQ:UTMD) pays an annual dividend of $1.20 per share and currently has a dividend yield of 1.75%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 26.26%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for UTMD .

What is Kevin L. Cornwell's approval rating as Utah Medical Products' CEO?

8 employees have rated Utah Medical Products Chief Executive Officer Kevin L. Cornwell on Glassdoor.com . Kevin L. Cornwell has an approval rating of 43% among the company's employees. This puts Kevin L. Cornwell in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG) , Walt Disney (DIS) , UnitedHealth Group (UNH) , Intuitive Surgical (ISRG) , Altria Group (MO) , SEI Investments (SEIC) , Trupanion (TRUP) , Visa (V) , Ventas (VTR) and

Who are Utah Medical Products' major shareholders?

Utah Medical Products' stock is owned by a variety of retail and institutional investors. Top institutional investors include Los Angeles Capital Management LLC (0.36%) and Bridge City Capital LLC (0.13%). Insiders that own company stock include Barbara A Payne, Barbara A Payne , Ernst G Hoyer and Paul O Richins. View institutional ownership trends .

How do I buy shares of Utah Medical Products?

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:UTMD

Utah Medical Products (UTMD) Stock Price, News & Analysis

→ Biden out June 13; Kamala won’t replace him? (From Paradigm Press) (Ad)

Free UTMD Stock Alerts

$68.34

-0.32 (-0.47%)

(As of 04/15/2024 ET)

Compare

Today's Range: $68.31
▼
$69.20
50-Day Range: $68.14
▼
$75.00
52-Week Range: $68.00
▼
$100.59

Volume: 40,402 shs
Average Volume: 26,293 shs
Market Capitalization: $245.27 million

P/E Ratio: 14.95
Dividend Yield: 1.76%
Price Target: N/A

Get Utah Medical Products alerts:

Utah Medical Products MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
1.65% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -0.94
Upright™ Environmental Score
News Sentiment: 1.08
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.49 out of 5 stars

Medical Sector

285th out of 929 stocks

Surgical & Medical Instruments Industry

33rd out of 97 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Utah Medical Products.

5.0

Short Interest

Percentage of Shares Shorted
1.65% of the float of Utah Medical Products has been sold short.
Short Interest Ratio / Days to Cover
Utah Medical Products has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Utah Medical Products has recently decreased by 8.60%, indicating that investor sentiment is improving significantly.

1.7

Dividend Strength

Dividend Yield
Utah Medical Products pays a meaningful dividend of 1.75%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Utah Medical Products has only been increasing its dividend for 2 years.
Dividend Coverage
The dividend payout ratio of Utah Medical Products is 26.26%. This payout ratio is at a healthy, sustainable level, below 75%.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Utah Medical Products has received a 60.58% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Blood pressure monitors" products. See details.
Environmental Sustainability
The Environmental Impact score for Utah Medical Products is -0.94.

3.4

News and Social Media Coverage

News Sentiment
Utah Medical Products has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Utah Medical Products this week, compared to 1 article on an average week.
MarketBeat Follows
2 people have added Utah Medical Products to their MarketBeat watchlist in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Utah Medical Products insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 6.50% of the stock of Utah Medical Products is held by insiders.
Percentage Held by Institutions
69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Utah Medical Products is 14.95, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.21.
Price to Earnings Ratio vs. Sector
The P/E ratio of Utah Medical Products is 14.95, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 248.92.
Price to Book Value per Share Ratio
Utah Medical Products has a P/B Ratio of 1.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

About Utah Medical Products Stock (NASDAQ:UTMD)

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

UTMD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

UTMD Stock News Headlines

April 12, 2024 | msn.com

Advance directives help people plan for their future medical care and quality of life

April 11, 2024 | fool.com

2 Beaten-Down Stocks That Could Be Ready to Soar

April 15, 2024 | Stansberry Research (Ad)

The "Smart Money" Is Ready for May 1st Are You?

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

March 14, 2024 | msn.com

Intermountain Health’s Transplant Program and patients celebrate life-saving medical milestone

March 11, 2024 | msn.com

Utah at the forefront of America’s alarming prescription drug shortages

March 4, 2024 | finance.yahoo.com

Utah Medical Products, Inc.'s (NASDAQ:UTMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

March 3, 2024 | msn.com

Utah’s 2024 legislative session bookended by DEI, transgender issues and new baseball, hockey stadiums

February 25, 2024 | msn.com

Utah Medicaid to provide up to 30-day supply of medication at no cost amid cyber outage

April 15, 2024 | Stansberry Research (Ad)

The "Smart Money" Is Ready for May 1st Are You?

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

February 18, 2024 | news.yahoo.com

Utah affected by E. coli contamination in raw milk cheese

February 6, 2024 | finance.yahoo.com

Utah Medical Products, Inc. Announces Quarterly Dividend

January 31, 2024 | finance.yahoo.com

Utah Medical Products Full Year 2023 Earnings: EPS: US$4.57 (vs US$4.53 in FY 2022)

January 30, 2024 | finanznachrichten.de

Utah Medical Products, Inc.: UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance

January 30, 2024 | finance.yahoo.com

UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance

January 30, 2024 | finance.yahoo.com

Utah Medical Products Inc (UTMD) Reports Mixed 2023 Financial Results

January 26, 2024 | finance.yahoo.com

Investors Could Be Concerned With Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

January 25, 2024 | yahoo.com

Big changes made to Utah’s controversial bathroom bill, but concerns remain

January 20, 2024 | msn.com

Should cold plunge tubs be regulated in Utah? Here’s what a legislative committee decided

January 19, 2024 | news.yahoo.com

The magic behind the high-impact discoveries from Utah’s universities

January 17, 2024 | finance.yahoo.com

Utah Medical Products, Inc. (UTMD)

January 11, 2024 | msn.com

Doctors urge Utah lawmakers to take immediate action on Great Salt Lake

January 10, 2024 | foxnews.com

University of Utah president discontinues diversity statements, says they will no longer be used in hiring

December 28, 2023 | forbes.com

Utah Power Of Attorney Form Template

December 27, 2023 | benzinga.com

Smart Decision: Brian Koopman Acquires Utah Medical Products Stock Options

December 22, 2023 | news.yahoo.com

Deer fly through Utah's skies for annual health checks

December 18, 2023 | health.usnews.com

Best Hospitals for Orthopedics in Utah

December 13, 2023 | finance.yahoo.com

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

See More Headlines

Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 1/30/2024
Ex-Dividend for 4/3 Dividend: 3/14/2024
Dividend Payable: 4/03/2024
Today: 4/15/2024
Next Earnings (Estimated): 4/23/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: Health Care Supplies
Current Symbol: NASDAQ:UTMD
CUSIP: 91748810
CIK: 706698
Web: www.utahmed.com
Phone: (801) 566-1200
Fax: 801-566-7305
Employees: 169
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $4.57
Trailing P/E Ratio: 14.95
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $16.64 million
Net Margins: 33.12%
Pretax Margin: 40.00%
Return on Equity: 13.53%
Return on Assets: 12.68%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 22.56
Quick Ratio: 20.53

Sales & Book Value

Annual Sales: $50.22 million
Price / Sales: 4.88
Cash Flow: $6.31 per share
Price / Cash Flow: 10.83
Book Value: $35.35 per share
Price / Book: 1.93

Miscellaneous

Outstanding Shares: 3,589,000
Free Float: 3,356,000
Market Cap: $245.27 million
Optionable: Not Optionable
Beta: 0.12

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Kevin L. Cornwell (Age 77)
Chairman, CEO, President & Secretary
Comp: $510.57k
Mr. Brian L. Koopman (Age 54)
Principal Financial Officer, Accounting Manager & Controller
Comp: $152.78k
Mark L. Fox
Vice President of Marketing
Marcena H. Clawson
Head of Corporate Sales

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

UTMD Stock Analysis - Frequently Asked Questions

How have UTMD shares performed in 2024?: Utah Medical Products' stock was trading at $84.22 at the beginning of 2024. Since then, UTMD stock has decreased by 18.9% and is now trading at $68.34.
View the best growth stocks for 2024 here.
When is Utah Medical Products' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024.
View our UTMD earnings forecast.
How were Utah Medical Products' earnings last quarter?: Utah Medical Products, Inc. (NASDAQ:UTMD) announced its quarterly earnings results on Tuesday, January, 30th. The medical instruments supplier reported $1.18 earnings per share for the quarter. The medical instruments supplier earned $12.33 million during the quarter. Utah Medical Products had a net margin of 33.12% and a trailing twelve-month return on equity of 13.53%.
How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?: Utah Medical Products announced a quarterly dividend on Tuesday, February 6th. Stockholders of record on Friday, March 15th will be given a dividend of $0.30 per share on Wednesday, April 3rd. This represents a $1.20 annualized dividend and a dividend yield of 1.76%. The ex-dividend date is Thursday, March 14th.
Read our dividend analysis for UTMD.
Is Utah Medical Products a good dividend stock?: Utah Medical Products (NASDAQ:UTMD) pays an annual dividend of $1.20 per share and currently has a dividend yield of 1.75%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 26.26%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for UTMD.

What is Kevin L. Cornwell's approval rating as Utah Medical Products' CEO?: 8 employees have rated Utah Medical Products Chief Executive Officer Kevin L. Cornwell on Glassdoor.com. Kevin L. Cornwell has an approval rating of 43% among the company's employees. This puts Kevin L. Cornwell in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Utah Medical Products own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG), Walt Disney (DIS), UnitedHealth Group (UNH), Intuitive Surgical (ISRG), Altria Group (MO), SEI Investments (SEIC), Trupanion (TRUP), Visa (V), Ventas (VTR) and
Who are Utah Medical Products' major shareholders?: Utah Medical Products' stock is owned by a variety of retail and institutional investors. Top institutional investors include Los Angeles Capital Management LLC (0.36%) and Bridge City Capital LLC (0.13%). Insiders that own company stock include Barbara A Payne, Barbara A Payne, Ernst G Hoyer and Paul O Richins.
View institutional ownership trends.
How do I buy shares of Utah Medical Products?: Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:UTMD) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial